This document discusses principles of sharing patient care records between healthcare providers. It outlines different methods of record sharing, from basic summaries to full integrated records. Key principles are that patient safety and privacy must be paramount. Effective record sharing requires reliable identification of patients, attribution of entries, and application of data standards. The document also examines what information primary care providers need from hospitals to effectively care for shared patients after discharge.
Medical Records and Health Information Technicians are also referred to as Medical Records Clerks, Health Information Clerks, Medical Records Technicians, File Clerks, Medical Records Coordinators, and Medical Records Analysts in the healthcare industry.
First eStandards conference Healthcare Executives Panel Dipak Kalrachronaki
This is the introduction to a panel in the first eStandards conference aiming to bring together with Hospital CIOs, actors in the healthcare system: representative of payers, healthprofessionals to get a sense of the issues with interoperability in largescale eHealth deployment. Here Prof. Dipak Kalra provides the perspective of a health professional
Health research, clinical registries, electronic health records – how do they...Koray Atalag
This is a talk I gave at my own organisation - National Institute for Health Innovation (NIHI) of the University of Auckland on 6 Aug 2014. Abstract as follows:
In this talk I’ll first cover the topic of clinical registry – an invaluable tool for supporting clinical practice but also gaining momentum in research and quality improvement. NIHI has been very active in this space: we have delivered the prestigious and highly successful National Cardiac Registry (ANZACS-QI) together with VIEW research team and also very recently launched the Gestational Diabetes Registry with Counties Manukau DHB & Diabetes Projects Trust. A few others are in likely to come down the line. This is a huge opportunity for health data driven research and NIHI to position itself as ‘the health data steward’ in the country given our independent status and existing IT infrastructure and “good culture” of working with health data . NIHI’s ‘health informatics’ twist in delivering these projects is how we go about defining ‘information’ – using a scientifically credible and robust methodology: openEHR. This is an international (and now national too) standard to non-ambiguously define health information so that they are easy to understand and also are computable. We build software (even automatically in some cases!) using models created by this formalism. I’ll give basics of openEHR approach and then walk you through how to make sense out of all these. Hopefully you may have an idea about its ‘value proposition’ (as business people call) or Science merit as I like to call it ;)
An Introduction to Clinical InformaticsCorinn Pope
Why should you care about clinical informatics? Because those who practice clinical informatics just may help our healthcare system get out of its funk and become an efficient, lean, and tech-savvy machine. Plus, the industry is growing and growing fast.
I gave this prezo to Auckland Regional Clinical IS Leadership Group on Feb 21, 2014. It shows how difficult it can be to deal with certain kinds of health information when developing systems by an impressive example (originally from Dr. Sam Heard). Therefore we need rigorous and scientific methods to tackle this - in this case using openEHR's multi-level modelling approach to create a single content model from which all health information exchange payload definitions will be derived. New Zealand's Interoperability Reference Architecture (HISO 10040) is underpinned by openEHR Archetypes to create this content model. The bottom line of the prezo is that almost every national programme starts health information standardisation from the wrong place; most of them are complex technical speficifications, like CDA, which are almost impossible for clinicians to comprehend and provide feedback. The process is flawed! Instead it should start from simple to understand representations, such as simple diagrams, mindmaps etc.and then handed over to techies once clinical validity and utility is agreed upon.That's the beauty of Archetype approach - great tooling and the Clinical Knowledge Manager (CKM) enable clinicians and other domain experts to collaborate and develop clinical models easily.
Medical Records and Health Information Technicians are also referred to as Medical Records Clerks, Health Information Clerks, Medical Records Technicians, File Clerks, Medical Records Coordinators, and Medical Records Analysts in the healthcare industry.
First eStandards conference Healthcare Executives Panel Dipak Kalrachronaki
This is the introduction to a panel in the first eStandards conference aiming to bring together with Hospital CIOs, actors in the healthcare system: representative of payers, healthprofessionals to get a sense of the issues with interoperability in largescale eHealth deployment. Here Prof. Dipak Kalra provides the perspective of a health professional
Health research, clinical registries, electronic health records – how do they...Koray Atalag
This is a talk I gave at my own organisation - National Institute for Health Innovation (NIHI) of the University of Auckland on 6 Aug 2014. Abstract as follows:
In this talk I’ll first cover the topic of clinical registry – an invaluable tool for supporting clinical practice but also gaining momentum in research and quality improvement. NIHI has been very active in this space: we have delivered the prestigious and highly successful National Cardiac Registry (ANZACS-QI) together with VIEW research team and also very recently launched the Gestational Diabetes Registry with Counties Manukau DHB & Diabetes Projects Trust. A few others are in likely to come down the line. This is a huge opportunity for health data driven research and NIHI to position itself as ‘the health data steward’ in the country given our independent status and existing IT infrastructure and “good culture” of working with health data . NIHI’s ‘health informatics’ twist in delivering these projects is how we go about defining ‘information’ – using a scientifically credible and robust methodology: openEHR. This is an international (and now national too) standard to non-ambiguously define health information so that they are easy to understand and also are computable. We build software (even automatically in some cases!) using models created by this formalism. I’ll give basics of openEHR approach and then walk you through how to make sense out of all these. Hopefully you may have an idea about its ‘value proposition’ (as business people call) or Science merit as I like to call it ;)
An Introduction to Clinical InformaticsCorinn Pope
Why should you care about clinical informatics? Because those who practice clinical informatics just may help our healthcare system get out of its funk and become an efficient, lean, and tech-savvy machine. Plus, the industry is growing and growing fast.
I gave this prezo to Auckland Regional Clinical IS Leadership Group on Feb 21, 2014. It shows how difficult it can be to deal with certain kinds of health information when developing systems by an impressive example (originally from Dr. Sam Heard). Therefore we need rigorous and scientific methods to tackle this - in this case using openEHR's multi-level modelling approach to create a single content model from which all health information exchange payload definitions will be derived. New Zealand's Interoperability Reference Architecture (HISO 10040) is underpinned by openEHR Archetypes to create this content model. The bottom line of the prezo is that almost every national programme starts health information standardisation from the wrong place; most of them are complex technical speficifications, like CDA, which are almost impossible for clinicians to comprehend and provide feedback. The process is flawed! Instead it should start from simple to understand representations, such as simple diagrams, mindmaps etc.and then handed over to techies once clinical validity and utility is agreed upon.That's the beauty of Archetype approach - great tooling and the Clinical Knowledge Manager (CKM) enable clinicians and other domain experts to collaborate and develop clinical models easily.
What is Health Informatics?
HI Goals
HI stakeholders
HI subfields / subspecialties
Healthcare trends & HI
HI professional environments
HI education / training opportunities & degrees
HI organizations / journals / meetings / events
HI professional certificates
HI books
It was an honor to be invited to present the Clinical Informatics keynote at the Health Informatics Society of Australia's #HIC16 conference on July 25, 2016.
Here is an outline of the topics that I spoke about in greater depth with audience of Clinicians & IT execs.
(In a separate presentation I spoke of the importance of engaging Patients in healthcare design, patient generated data, self-care, crowdsourcing, etc)
Presented at the 7th Healthcare CIO Program, Hospital Administration School, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand on July 8, 2016
Why is there a need for nursing documentation
Good record keeping promotes
Who reads nursing records
What is expected of a registered nurse
Record keeping should demonstrate
Nurses accountability
Legal Matters of Nursing Record's
What is Health Informatics?
HI Goals
HI stakeholders
HI subfields / subspecialties
Healthcare trends & HI
HI professional environments
HI education / training opportunities & degrees
HI organizations / journals / meetings / events
HI professional certificates
HI books
It was an honor to be invited to present the Clinical Informatics keynote at the Health Informatics Society of Australia's #HIC16 conference on July 25, 2016.
Here is an outline of the topics that I spoke about in greater depth with audience of Clinicians & IT execs.
(In a separate presentation I spoke of the importance of engaging Patients in healthcare design, patient generated data, self-care, crowdsourcing, etc)
Presented at the 7th Healthcare CIO Program, Hospital Administration School, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand on July 8, 2016
Why is there a need for nursing documentation
Good record keeping promotes
Who reads nursing records
What is expected of a registered nurse
Record keeping should demonstrate
Nurses accountability
Legal Matters of Nursing Record's
Computer validation of e-source and EHR in clinical trials-KuchinkeWolfgang Kuchinke
Clinical Trials in the Learning Health System (LHS): Computer System Validation of eSource and EHR Data.
The question that was addressed: How to make a clinical trial data management system that uses EHR data, Patient Reported Outcome (PRO) and eSource data as part of the Learning Health System compliant with regulations and with Good Clinical Practice (GCP)?
The Learning Health System (LHS) connects health care with translational and clinical research. It generates new medical knowledge as a by-product of the care process and its aim is to improve health and safety of patients. The LHS generates and applies knowledge. For this purpose, clinical research, which is research involving humans, must be part of the LHS. Two general types of research exists: observational studies and clinical trials.
Clinical data drive the LHS, because results from randomized controlled trials are seen as “gold standard” for medical evidence. For this reason the concept of using data gathered directly from the patient care environment has enormous potential for accelerating the rate at which useful knowledge is generated.
All computer systems involved in clinical trials must undergo Computer System Validation (CSV). For this process, a legal framework for the TRANSFoRm project was developed. It was used for data privacy analysis of the data flow in two research use cases: an epidemiological cohort study on Diabetes and a randomised clinical trial about different GORD treatment regimes.
Computerized system validation is the documented process to produce evidence that a computerized system does exactly what it is designed to do in a consistent and reproducible manner. The validation of electronic source data in clinical trials presents many challenges because of the blurring of the border between care and research. Here we present our approach for the validation of eSource data capture and the developed documentation for the CSV of the complete data flow in the LHS developed by the TRANSFoRm project. An important part hereby played the GORD Valuation Study.
Computer System Validation - privacy zones, eSource and EHR data in clinical ...Wolfgang Kuchinke
Clinical Trials in the Learning Health System (LHS): Computer System Validation of eSource and EHR Data.
The question that was addressed: How to make a clinical trial data management system that uses EHR data, Patient Reported Outcome (PRO) and eSource data as part of the Learning Health System compliant with regulations and with Good Clinical Practice (GCP)?
The Learning Health System (LHS) connects health care with translational and clinical research. It generates new medical knowledge as a by-product of the care process and its aim is to improve health and safety of patients. The LHS generates and applies knowledge. For this purpose, clinical research, which is research involving humans, must be part of the LHS. Two general types of research exists: observational studies and clinical trials.
Clinical data drive the LHS, because results from randomized controlled trials are seen as “gold standard” for medical evidence. For this reason the concept of using data gathered directly from the patient care environment has enormous potential for accelerating the rate at which useful knowledge is generated.
All computer systems involved in clinical trials must undergo Computer System Validation (CSV). For this process, a legal framework for the TRANSFoRm project was developed. It was used for data privacy analysis of the data flow in two research use cases: an epidemiological cohort study on Diabetes and a randomised clinical trial about different GORD treatment regimes.
Computerized system validation is the documented process to produce evidence that a computerized system does exactly what it is designed to do in a consistent and reproducible manner. The validation of electronic source data in clinical trials presents many challenges because of the blurring of the border between care and research. Here we present our approach for the validation of eSource data capture and the developed documentation for the CSV of the complete data flow in the LHS developed by the TRANSFoRm project. An important part hereby played the GORD Valuation Study.
Computer System Validation with privacy zones, e-source and clinical trials b...Wolfgang Kuchinke
Clinical Trials in the Learning Health System: Computer System Validation of eSource and EHR Data. Basic question is how to make a clinical trial data management system that uses EHR data, Patient Reported Outcome (PRO) and eSource data as part of the Learning Health System compliant with regulations and with Good Clinical Practice (GCP)? Computer System Validation (CSV) is a requirement for all computer systems involved in clinical trials for drug submission. It consists of documented processes to produce evidence that a computerized system does exactly what it is designed to do in a consistent and reproducible manner. Validation begins with the system requirements definition and continues until system retirement. For example, the components of a clinical trials
framework used in our case are: Patient eligibility checks and enrolment, pre-population of eCRFs with data from EHRs, PROM data collection by patients, storing of a copy of study data in the EHR, and validation of the Study System that coordinates all study and data collection events.
eSource direct data entry in clinical trials and GCP requirements. It is the duty of physicians who are involved in medical research to protect the privacy and confidentiality of personal information of research subjects. Any eSource system should be fully compliant with the provisions of applicable data protection legislation. This creates the need to develop and implement processes that ensure the continuous control of the investigators over these data. This has to be the focus of CSV. Clinical Data drive the LHS. The results from randomized controlled trials are seen as the “gold standard” for medical evidence, but such trials are often performed outside the usual system of care and recruit highly selected populations. For this reason, the concept of using data gathered directly from the patient care environment has enormous potential for accelerating the rate at which useful knowledge is generated.
This leads to the requirement for validating electronic source data in clinical trials. This includes validation for clinical data that is either captured from the subject directly or from the subject’s medical records. The problem is the correct and appropriate system validation of electronic source data. The main componenets of CSV are the Validation Master Plan), User Requirements Specification, Hardware Requirements Specification, Design qualification, Installation qualification, Operational qualification, Performance qualification.
Any instrument used to capture source data should ensure that the data are captured as specified within the protocol. Source data should be accurate, legible, contemporaneous, original, attributable, complete and consistent. An audit trail should be maintained as part of the source documents for the original creation and subsequent modification of all source data.
Talk at Heart Rhythm Society's 2013 annual Sessions discussing why and how patients will be able to obtain data from their implantable cardiac devices.
iHT² Health IT Summit Beverly Hills – Case Study "The EHR & Quality: The Current Evidence" Abha Agrawal, MD, FACP, COO & VP of Medical Affairs, Norwegian American Hospital
Case Study "The EHR & Quality: The Current Evidence"
∙ Understand where EHRs have demonstrated evidence based quality improvement
∙ Learn what areas for improvement exist to improve quality and physician productivity
∙ Discuss how results can be driven across diverse care settings and systems
∙ Identify unintended consequences of HIT
Healthcare IT has a last mile problem. Use of new clinical systems is being mandated, often at the expense of effectiveness and efficiency. The challenge is balancing the implementation of these new requirements with the need to optimize workflow for doctors and nurses. Learn how increasing the usability of clinical systems will result in increased productivity, improved clinician satisfaction, and improved patient care.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Keynote Presentation: Sharing of Care Records Dr. Maureen Baker
1. Sharing of Care Records
Dr Maureen Baker CBE DM FRCGP
Chair of Council
RCGP
2. Declaration of interests
• Strategic Safety Adviser to HSCIC
• Previously Clinical Director of Patient Safety
HSCIC (NHS CFH)
• Led development of NHS ISB safety standards
(ISB 029 and 060)
3. Record sharing methodologies
• View of Information (Summary Care Record)
• Access to electronic record (where view is
governed by sharing model and patient
consent)
• Inter-operable records
• Full access to full shared record
4. Principles on record sharing
• Patient safety is paramount
• Personal information should be subject to
highest standards of privacy and
confidentiality
• Tension between above two must be properly
governed (eg Caldicott Guardian)
• Views and entries must be reliably timed and
traceable to individual caregiver
5. Factors to consider
• Could be creating long-term record (many years
and multiple episodes of care in multiple
settings)
• Major differences from record focusing on one
episode of care (eg hospital in-patient)
• Safety dimension in accurately identifying critical
information quickly (eg drugs, allergies, results)
• IG dimension in protecting info that patient does
not want widely shared
6. Designing for safety
• NHS needs systems as safe as design and forethought will
allow
• System designers need to think how technology can
support clinicians in safe practice
• Systems need to be tested in 'real' environments
• Safe view (right patient, right information)
• Safe transfer (retention of semantic meaning; right field
to right field)
• NHS safety standards must be applied (NHS number; ISB
029)
8. Data to inform
commissioning decisions
• Any data from anywhere in NHS system has
potential for commissioning
• Demographics; Drugs; Interventions;
Outcomes
• GPs currently have most comprehensive
coded datasets over longer periods of time
9. Rubbish in rubbish out
• Data quality is a patient
safety issue
• Data quality is a
commissioning quality
issue
• Need a system-wide
understanding of
importance - but also
limitations - of data
quality
10. Clinical information for commissioning
• Need routine capture as 'by-product' of care process
• Must minimise (preferably eliminate) burden of data
capture for clinicians
• Appropriate patient consent models MUST be in
place
• GPs and practices need mechanisms to allow
patients to enable patients to exercise their choice
11. What GPs want
• Timely discharge information
• Results
• Key events during admission (not always clear,
or on discharge summary)
• Drugs at discharge and reasons why any
changes made to previous regime
• Follow-up information/requests
12. What GPs
DON’T want
• Blank or minimal information
• Vast amounts of detail specific to
admission (eg nursing notes)
• Lists of instructions (eg GP to.... –
Grrr!)
13. Safety handover guidance
• Based on extensive work
by national and
international organisations
• Endorsed by the DHIDs
National Clinical Content
and Requirements Board
in partnership with the
Royal College of Physicians
(RCP)
• Contains a check list for
Clinical Safety Officers to
use when reviewing
handover IT systems for
use in the NHS
14. Guiding principles
• The data items constitute a core set of issues which must
be used in any and every electronic clinical handover
• The core set of issues is necessary but not sufficient for
any and every electronic clinical handover – each health
care setting will have its own, additional set of essential
data items to be transferred in a clinical handover
• The guiding principles and related data items for ensuring
safer clinical handovers are additional to, and not instead
of, all usual clinical safety assurance measures as set out in
Data Set Change Notices (DSCNs) 14/2009 and 18/2009
15. Data items
• Name (‘last name’ and ‘first name’ as endorsed by the ISB standard
04/2009)
• Date of Birth (DOB)
• NHS Number
• What is wrong with this patient? e.g. Active clinical problems
• What has been done? e.g. Relevant investigations & treatments to
date
• What needs to be done? e.g. Action plan – including when and by
whom
• Medications – current
• Anything else I should know? (eg. Alerts such as risks, allergies,
statuses, disability; resuscitation status; advance directives; next of
kin)
• Responsible consultant/team/clinician e.g. GP or nurse making the
handover
16. Conclusions
• Very few/if any truly integrated records in NHS
• Integrated OR interoperable?
• Local health economies and emerging
Integrated Care Organisations should consider
options for integrated records
• Basic standards already in place – NHS no.,
safety standards, electronic handover guidance